X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cirrhotic patient (72) 72
life sciences & biomedicine (58) 58
science & technology (58) 58
humans (54) 54
cirrhotic patients (45) 45
female (30) 30
male (30) 30
middle aged (29) 29
liver cirrhosis (26) 26
adult (25) 25
gastroenterology & hepatology (25) 25
aged (24) 24
hepatic encephalopathy (19) 19
liver cirrhosis - complications (19) 19
cirrhotic-patients (18) 18
portal hypertension (18) 18
risk factors (15) 15
spontaneous bacterial peritonitis (15) 15
treatment outcome (14) 14
surgery (13) 13
hepatocellular carcinoma (12) 12
cirrhosis (11) 11
liver (10) 10
liver transplantation (10) 10
umcg approved (9) 9
liver cirrhosis - mortality (8) 8
mortality (8) 8
retrospective studies (8) 8
transjugular intrahepatic portosystemic shunt (8) 8
transplantation (8) 8
hepatology (7) 7
von-willebrand-factor (7) 7
adolescent (6) 6
aged, 80 and over (6) 6
ascites (6) 6
esophageal varix (6) 6
liver cirrhosis - metabolism (6) 6
liver diseases (6) 6
medicine & public health (6) 6
patients (6) 6
pharmacology & pharmacy (6) 6
time factors (6) 6
abridged index medicus (5) 5
gastroenterology (5) 5
gastroenterology and hepatology (5) 5
liver cancer (5) 5
liver disease (5) 5
liver diseases - physiopathology (5) 5
liver transplantation - adverse effects (5) 5
oncology (5) 5
portal vein thrombosis (5) 5
prognosis (5) 5
recurrence (5) 5
risk assessment (5) 5
survival rate (5) 5
analysis (4) 4
ascitic fluid (4) 4
bacterial translocation (4) 4
bleeding (4) 4
carcinoma, hepatocellular - surgery (4) 4
care and treatment (4) 4
chronic liver disease (4) 4
conventional coagulation tests (4) 4
drug administration schedule (4) 4
esophageal and gastric varices - etiology (4) 4
esophageal and gastric varices - mortality (4) 4
gastrointestinal bleeding (4) 4
gastrointestinal hemorrhage - mortality (4) 4
hematology (4) 4
hemorrhage (4) 4
hemostasis (4) 4
hepatitis c (4) 4
hepatorenal syndrome (4) 4
laparoscopic cholecystectomy (4) 4
liver cirrhosis - diagnosis (4) 4
liver cirrhosis - physiopathology (4) 4
liver diseases - blood (4) 4
liver diseases - complications (4) 4
liver neoplasms - pathology (4) 4
liver neoplasms - surgery (4) 4
liver resection (4) 4
medical research (4) 4
medicine (4) 4
medicine, experimental (4) 4
original (4) 4
original article (4) 4
pharmacokinetics (4) 4
portal vein (4) 4
portal-vein thrombosis (4) 4
prevalence (4) 4
prospective studies (4) 4
severity of illness index (4) 4
studies (4) 4
thrombosis - etiology (4) 4
transfusion requirements (4) 4
transplant surgery (4) 4
variceal bleeding (4) 4
acute kidney injury (3) 3
administration, oral (3) 3
age (3) 3
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (164) 164
Korean (2) 2
Chinese (1) 1
French (1) 1
German (1) 1
Japanese (1) 1
Portuguese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Il Giornale di chirurgia, ISSN 0391-9005, 01/2018, Volume 39, Issue 1, pp. 20 - 23
The incidence of abdominal wall hernia in cirrhotic patients with ascites is between 20 and 40%. Controversies regarding the treatment modality and surgical... 
Abdominal wall incisional hernia | Cirrhotic patients | Index Medicus
Journal Article
Journal Article
Hu li za zhi, ISSN 0047-262X, 06/2018, Volume 65, Issue 3, pp. 38 - 46
Journal Article
Transplantation, ISSN 0041-1337, 12/2012, Volume 94, Issue 11, pp. 1145 - 1153
Journal Article
Journal of Research in Clinical Medicine, 02/2020, Volume 8, Issue 1, pp. 23 - 23
Introduction: Considering that portal hypertension is principally caused by hepatic fibrosis, some studies postulated the predictive value of serum liver... 
cirrhotic patients | noninvasive indices | portal hypertension
Journal Article
Investigational new drugs, ISSN 0167-6997, 2/2012, Volume 30, Issue 1, pp. 376 - 381
Purpose The only drug that improves survival in hepatocellular carcinoma is sorafenib. FOLFOX-4 regimen is safe and widely used in patients with colorectal... 
5-fluorouracil | Chemotherapy | Oxaliplatin | Medicine & Public Health | Cirrhotic patients | Oncology | Hepatocellular carcinoma | Pharmacology/Toxicology | Liver transplantation | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | Leucovorin - administration & dosage | Carcinoma, Hepatocellular - mortality | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Liver Transplantation - adverse effects | Humans | Middle Aged | Liver Cirrhosis - mortality | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Liver Neoplasms - mortality | Feasibility Studies | Liver Neoplasms - etiology | Organoplatinum Compounds - administration & dosage | Carcinoma, Hepatocellular - drug therapy | Fluorouracil - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Time Factors | Female | Liver Neoplasms - pathology | Carcinoma, Hepatocellular - etiology | Retrospective Studies | Chemotherapy, Adjuvant | Drug Administration Schedule | Liver Cirrhosis - complications | Liver Neoplasms - drug therapy | Carcinoma, Hepatocellular - surgery | Liver Neoplasms - surgery | Liver Transplantation - mortality | Treatment Outcome | Disease-Free Survival | Carcinoma, Hepatocellular - pathology | Survival Analysis | Aged | Organoplatinum Compounds - adverse effects | Paris | Complications and side effects | Care and treatment | Patient outcomes | Liver | Dosage and administration | Leucovorin | Transplantation | Hepatoma | Health aspects | Fluorouracil | Studies | Liver cancer | Pharmacology | Transplants & implants | Liver cirrhosis | Index Medicus
Journal Article
Journal Article